Product NDC: | 17478-120 |
Proprietary Name: | Clindamycin |
Non Proprietary Name: | Clindamycin Phosphate |
Active Ingredient(s): | 300 mg/50mL & nbsp; Clindamycin Phosphate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-120 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA203048 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130405 |
Package NDC: | 17478-120-50 |
Package Description: | 1 BOTTLE, GLASS in 1 CARTON (17478-120-50) > 50 mL in 1 BOTTLE, GLASS |
NDC Code | 17478-120-50 |
Proprietary Name | Clindamycin |
Package Description | 1 BOTTLE, GLASS in 1 CARTON (17478-120-50) > 50 mL in 1 BOTTLE, GLASS |
Product NDC | 17478-120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin Phosphate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130405 |
Marketing Category Name | ANDA |
Labeler Name | Akorn, Inc. |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 300 |
Strength Unit | mg/50mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |